TNFRSF12A 抗体 (PE)
Quick Overview for TNFRSF12A 抗体 (PE) (ABIN2749122)
抗原
See all TNFRSF12A 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    
- 
                                            
原理
 - Anti-Hu CD266 PE
 - 
                                            
特异性
 - The mouse monoclonal antibody ITEM-4 recognizes an extracellular epitope of CD266 / TWEAK R, a TNFR superfamily receptor for CD255 / TWEAK, a TNF-like weak inducer of apoptosis.
 - 
                                            
交叉反应 (详细)
 - Human, Mouse
 - 
                                            
纯化方法
 - Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.
 - 
                                            
免疫原
 - human CD266-transfected P815 cells
 - 
                                            
亚型
 - IgG2b
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
应用备注
 - Flow cytometry: Recommended dilution: 2-4 μg/mL.
 - 
                                            
限制
 - 仅限研究用
 
 - 
                                            
 - 
    
- 
                                            
浓度
 - 0.1 mg/mL
 - 
                                            
缓冲液
 - Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
 - 
                                            
储存液
 - Sodium azide
 - 
                                            
注意事项
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
储存条件
 - 4 °C
 - 
                                            
储存方法
 - Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
 
 - 
                                            
 - 
    
- 
                                            : "Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer."    in: Experimental and therapeutic medicine, Vol. 2, Issue 1, pp. 103-108, (2012)         (PubMed).        
: "Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 185, Issue 3, pp. 1593-605, (2010) (PubMed).
: "Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 170, Issue 1, pp. 341-8, (2002) (PubMed).
 
 - 
                                            : "Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer."    in: Experimental and therapeutic medicine, Vol. 2, Issue 1, pp. 103-108, (2012)         (PubMed).        
 - 
    
- TNFRSF12A (Tumor Necrosis Factor Receptor Superfamily, Member 12A (TNFRSF12A))
 - 
                                            
别名
 - CD266
 - 
                                            
背景
 - TNF receptor superfamily member 12A,CD266 / TWEAK R (TNFRSF12A), also known as FN14 (fibroblast growth factor-inducible 14) is a receptor for CD255 / TWEAK, the TNF-like weak inducer of apoptosis. CD266 is expressed on endothelial cells, as well as on some cancer tissues, and plays a role in CD255-induced endothelial cell migration, proliferation, and angiogenesis. The CD255-CD266 interaction, or antibody-mediated triggering of CD266 is also able to induce apoptosis and necrosis in CD266-positive cells (including tumor cells), which might have therapeutic potential.,TWEAKR, FN14, TNFRSF12A
 - 
                                            
基因ID
 - 51330
 - 
                                            
UniProt
 - Q9NP84
 - 
                                            
途径
 - Apoptosis, Regulation of Cell Size
 
抗原
 -